OOverture Life
Overture Life is a clinical-stage fertility technology company that automates the IVF and embryology lab through robotics, aiming to make fertility treatment cheaper, more consistent and more widely accessible. Its products include DaVitri (a portable/automated embryology lab for egg vitrification), ICSI.A for automated Piezo-ICSI sperm injection, and m|z metabolomic embryo profiling; its robot performed the fertilizations behind the world's first babies conceived by a sperm-injecting robot (reported by MIT Technology Review in 2023). Founded in Madrid in 2017 by Martin Varsavsky and Santiago Munne, it has raised roughly $57M total, including a $20.6M strategic round in April 2025 led by Overwater Ventures, and has expanded into the U.S. with a CLIA-licensed clinical lab and operations hub in Dallas; R&D remains in Spain.
Founders
Global models 5
C
A
F
A
FIn the same niche 72 others
See all in the Start-ups Map →
A
I
A
N
GNotes: Most funded first
Investors 11
Open as list →
E
O
R
O
K
F
GFunding rounds 4
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-11-04 | Venture Debt | €20M | European Investment Bank |
| 2025-04-24 | Series C | $20.6M |
Overwater Ventures
+2 more
|
| 2021-05-26 | Series B | $15M |
Octopus Ventures
+4 more
|
| 2019-07-23 | Series A | $20M |
Lead not disclosed
+6 more
|